cjc ipamorelin and tirzepatide CJC-1295 / | Clinician-Reviewed Peptide Therapy CJC-1295 Ipamorelin in Houston |
Description
Whether you visit our office or receive virtual care, our healthcare professionals provide medication education and personalized guidance on nutrition and overall wellness
Both medications are used to manage type 2 diabetes and aid in weight loss
The 8.8 average and tight score range (6.5-10.0) demonstrate consistency that no other Polaris product matches
In the 2021 STEP-1 trial (1,961 adults with obesity or overweight), participants receiving semaglutide plus lifestyle intervention experienced a 14.9% mean weight loss after 68 weeks, while those on placebo lost only 2.4%
It combines naloxone and buprenorphine, which help curtail opioid cravings and quell withdrawal symptoms
Mounjaro (tirzepatide) EPAR Product Information
